Zealand Pharma A Asset Turnover Ratio (ZEAL), as of fourth quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Zealand Pharma A  (NASDAQ: ZEAL)
 

Zealand Pharma A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Zealand Pharma A asset turnover ratio, the ability of Zealand Pharma A's assets to generate revenue in the fourth quarter 2021, increased sequentially to 0.03 in the fourth quarter (Dec 31 2021), yet the ratio remained below the average, as ZEAL's position remain challenging.

Within sector 175 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2021 compared to the preceding quarter from 0 to 3478.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZEAL Asset Turnover Ratio (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Asset Change 84.08 % 537.68 % 756.51 % 994.64 % 147.56 %
Y / Y Revenue Change 424.05 % - - - -
Asset Turnover Ratio (TTM) 0.03 - - - 0.04
ZEAL's Total Ranking # 3478 # 0 # 0 # 0 #
Seq. Asset Change -74.14 % 0 % 0 % 611.72 % -10.4 %
Seq. Revenue Change - - - - 500.78 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 176
Healthcare Sector # 493
Overall Market # 3478

Asset Turnover Ratio Statistics
High Average Low
0.14 0.14 0.14
(Dec 31 2021)  




ZEAL Company Profile • Back to ZEAL Efficiency Comparisons • Compare ZEAL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2021 Assets at quarter ending Dec 31 2021
Elicio Therapeutics Inc   0.23 $ 27.506  Millions$ 117.753  Millions
Clearpoint Neuro Inc   0.23 $ 16.299  Millions$ 70.218  Millions
Ultragenyx Pharmaceutical Inc   0.23 $ 351.406  Millions$ 1,529.351  Millions
Zevra Therapeutics Inc   0.23 $ 28.650  Millions$ 124.840  Millions
Biora Therapeutics Inc   0.23 $ 25.606  Millions$ 113.761  Millions
Concert Pharmaceuticals Inc   0.22 $ 32.578  Millions$ 145.555  Millions
Outset Medical Inc   0.22 $ 102.602  Millions$ 459.228  Millions
Burning Rock Biotech Limited  0.22 $ 79.694  Millions$ 357.562  Millions
Transmedics Group Inc   0.22 $ 30.262  Millions$ 138.084  Millions
Orphazyme A  0.22 $ 5.758  Millions$ 26.365  Millions
Alerislife Inc   0.22 $ 934.593  Millions$ 4,313.815  Millions
Ligand Pharmaceuticals Incorporated  0.22 $ 277.133  Millions$ 1,280.663  Millions
Personalis Inc   0.22 $ 85.494  Millions$ 395.517  Millions
Palvella Therapeutics Inc   0.21 $ 31.418  Millions$ 147.140  Millions
Quanterix Corporation  0.21 $ 110.556  Millions$ 518.269  Millions
Lite Strategy Inc   0.21 $ 37.814  Millions$ 177.667  Millions
Castle Biosciences Inc   0.21 $ 94.085  Millions$ 442.282  Millions
Polarityte Inc   0.21 $ 9.404  Millions$ 44.478  Millions
Nexgel Inc   0.21 $ 1.552  Millions$ 7.365  Millions
Twist Bioscience Corporation  0.21 $ 146.190  Millions$ 701.695  Millions
Enanta Pharmaceuticals Inc  0.21 $ 92.979  Millions$ 448.946  Millions
Viveve Medical Inc   0.20 $ 6.426  Millions$ 31.999  Millions
Arrowhead Pharmaceuticals Inc   0.20 $ 144.423  Millions$ 728.005  Millions
Veracyte Inc   0.20 $ 219.514  Millions$ 1,106.688  Millions
Pulmonx Corporation  0.20 $ 48.416  Millions$ 246.550  Millions
Bellicum Pharmaceuticals Inc   0.20 $ 6.232  Millions$ 31.745  Millions
Guardion Health Sciences Inc   0.20 $ 7.233  Millions$ 37.015  Millions
Macrogenics Inc   0.19 $ 77.447  Millions$ 397.190  Millions
Ocular Therapeutix Inc   0.19 $ 43.522  Millions$ 224.093  Millions
Maxcyte inc   0.19 $ 33.894  Millions$ 176.684  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.